Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Barré

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Medecine Sciences : M/S|April 24, 2010
[Transient transformation as a permanent oncogenic loop]Olivier Coqueret, Benjamin Barré
Cell Cycle (Georgetown, Tex.)|December 15, 2010
Phosphorylation of the p52 NF-κB subunitBenjamin Barré, Neil D Perkins
Molecular Cell|June 2, 2010
The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosisBenjamin Barré, Neil D Perkins
The EMBO Journal|October 27, 2007
A cell cycle regulatory network controlling NF-kappaB subunit activity and functionBenjamin Barré, Neil D Perkins
The Journal of Biological Chemistry|November 20, 2002
Opposite regulation of myc and p21waf1 transcription by STAT3 proteinsBenjamin Barré, Sylvie Avril, Olivier Coqueret
The Journal of Biological Chemistry|January 29, 2005
The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoterBenjamin Barré, Arnaud Vigneron, Olivier Coqueret
Cell Cycle (Georgetown, Tex.)|December 7, 2010
Regulation of activity and function of the p52 NF-κB subunit following DNA damageBenjamin Barré, Olivier Coqueret, Neil D Perkins
JAK-STAT|September 24, 2013
Circulating miRNAs as new activators of the JAK-STAT3 pathwayDavid Lam, Benjamin Barré, Catherine Guette, et al.
JAK-STAT|September 27, 2013
STAT3 as a new autophagy regulatorBarbara Jonchère, Audrey Bélanger, Catherine Guette, et al.
JAK-STAT|September 27, 2013
How should we define STAT3 as an oncogene and as a potential target for therapy?Hélène Sellier, Amélie Rébillard, Catherine Guette, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Medecine Sciences : M/S|April 24, 2010
[Transient transformation as a permanent oncogenic loop]Olivier Coqueret, Benjamin Barré
Cell Cycle (Georgetown, Tex.)|December 15, 2010
Phosphorylation of the p52 NF-κB subunitBenjamin Barré, Neil D Perkins
Molecular Cell|June 2, 2010
The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosisBenjamin Barré, Neil D Perkins
The EMBO Journal|October 27, 2007
A cell cycle regulatory network controlling NF-kappaB subunit activity and functionBenjamin Barré, Neil D Perkins
The Journal of Biological Chemistry|November 20, 2002
Opposite regulation of myc and p21waf1 transcription by STAT3 proteinsBenjamin Barré, Sylvie Avril, Olivier Coqueret
The Journal of Biological Chemistry|January 29, 2005
The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoterBenjamin Barré, Arnaud Vigneron, Olivier Coqueret
Cell Cycle (Georgetown, Tex.)|December 7, 2010
Regulation of activity and function of the p52 NF-κB subunit following DNA damageBenjamin Barré, Olivier Coqueret, Neil D Perkins
JAK-STAT|September 24, 2013
Circulating miRNAs as new activators of the JAK-STAT3 pathwayDavid Lam, Benjamin Barré, Catherine Guette, et al.
JAK-STAT|September 27, 2013
STAT3 as a new autophagy regulatorBarbara Jonchère, Audrey Bélanger, Catherine Guette, et al.
JAK-STAT|September 27, 2013
How should we define STAT3 as an oncogene and as a potential target for therapy?Hélène Sellier, Amélie Rébillard, Catherine Guette, et al.
Pageof 3